<DOC>
	<DOCNO>NCT00994461</DOCNO>
	<brief_summary>A study confirm superiority celecoxib 100 mg BID loxoprofen 60 mg TID incidence gastroduodenal endoscopic ulcer 2 week treatment .</brief_summary>
	<brief_title>Study Of Celecoxib In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Loxoprofen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Healthy Volunteers Endoscopic evidence ulceration , erosion active bleeding etc . esophagus , stomach , pylorus and/or duodenum prior treatment endoscopy A history gastrointestinal ulcer Any use celecoxib , nonsteroidal antiinflammatory drug ( include aspirin ) , antiulcer medication , antacid , systemic steroid antibiotic within four week prior first dose study medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Endoscopy</keyword>
</DOC>